Ubs Group Ag Sight Sciences, Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

A detailed history of Ubs Group Ag transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 2,855,850 shares of SGHT stock, worth $15.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,855,850
Previous 2,871,764 0.55%
Holding current value
$15.1 Million
Previous $15.2 Million 25.63%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$5.13 - $7.15 $81,638 - $113,785
-15,914 Reduced 0.55%
2,855,850 $19 Million
Q1 2024

May 13, 2024
SELL
$4.02 - $5.89 $97,259 - $142,502
-24,194 Reduced 0.84%
2,871,764 $15.2 Million
Q4 2023

Feb 09, 2024
BUY
$1.29 - $5.86 $3.72 Million - $16.9 Million
2,881,750 Added 20282.59%
2,895,958 $14.9 Million
Q3 2023

Nov 09, 2023
SELL
$2.88 - $8.8 $17,314 - $52,905
-6,012 Reduced 29.73%
14,208 $47,000
Q2 2023

Aug 11, 2023
BUY
$7.46 - $10.67 $75,413 - $107,863
10,109 Added 99.98%
20,220 $167,000
Q1 2023

May 12, 2023
BUY
$8.44 - $13.35 $35,338 - $55,896
4,187 Added 70.68%
10,111 $88,000
Q4 2022

Feb 08, 2023
SELL
$5.58 - $13.94 $104,145 - $260,176
-18,664 Reduced 75.91%
5,924 $72,000
Q3 2022

Nov 10, 2022
BUY
$6.1 - $11.41 $149,986 - $280,549
24,588 New
24,588 $156,000
Q2 2022

Aug 10, 2022
SELL
$6.61 - $11.99 $8,830 - $16,018
-1,336 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$11.56 - $17.9 $28,946 - $44,821
-2,504 Reduced 65.21%
1,336 $15,000
Q4 2021

Feb 14, 2022
BUY
$17.36 - $27.36 $66,662 - $105,062
3,840 New
3,840 $67,000

Others Institutions Holding SGHT

# of Institutions
73
Shares Held
21.4M
Call Options Held
30.7K
Put Options Held
18.6K
View Full List

About Sight Sciences, Inc.

SGHT Quotes by TradingView
  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $253M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email